Underwater

A follow-up to Eight Days, published August 18.

On August 5, Paul Meister wired $5 million into Aptiv stock. Over the next eight days, CEO Kevin Clark added $2.5 million, Sean Mahoney $553K, Hakan Agnevall $199K. Four insiders, $8.3 million, a company trading near its 52-week low after spinning off Versigent.

I called it a high-conviction cluster. I flagged the cross-company convergence with homebuilders. I noted the analyst consensus — 20 firms, average target $78, 57% upside.

Four weeks later, every one of them is losing money.

$8.3 million committed. Four insiders. Every position red.

What went wrong

The stock hit a new 52-week low of $44.52 in late August — below every cluster buy price. The post-spin-off “New Aptiv” that was supposed to be a focused electrical architecture play became an analyst downgrade target:

China weakness, launch delays, software-revenue timing. The $300 million guidance cut at the midpoint wasn’t a surprise — it was the reason the stock was at a 52-week low when insiders bought. They knew all of this. They bought anyway.

That’s either conviction or miscalculation. Four weeks is too early to know which.

What hasn’t happened

Two things matter more than the price.

First: zero sells. Not one of the four has filed a Form 4 disposing of shares. In a thesis under stress, the absence of selling is the most important data point. Insiders who panic-sell after buying are admitting the thesis broke. These four are holding.

Second: zero follow-through buys. Compare this to Dick’s Sporting Goods, where director Colombo bought three times in six days — including once at a higher price than his original entry. That’s what escalating conviction looks like. At Aptiv, the silence since August 13 is notable. No one is averaging down into the new 52-week low.

Holding is not the same as doubling down.

The honest assessment

Meister’s $5 million buy remains the anchor. He’s a sophisticated allocator — founder of Liberty Lane Partners, lead independent director. His entry at $47.33 was the largest single insider purchase I’ve tracked outside of founder-CEOs. He’s down 1.7%. Not comfortable, but not catastrophic.

The analyst consensus still says he’s early. Even after the downgrade parade, the average price target is ~$69 — 48% above today’s price. Eighteen analysts. Not one has a target below the current stock price. The gap between where Wall Street thinks this company should trade and where it actually does is the widest I’ve seen in any name I cover.

But analyst targets are not the same as reality. And insiders aren’t always right.

What resolves this

Three triggers:

Confirmation: Any insider buys additional shares at current levels. Especially Meister averaging down from $47.33. That would echo the DKS Colombo pattern — escalating conviction at higher cost basis.

Invalidation: Any insider sells. Even a partial disposition breaks the thesis. $8.3 million of conviction only works if the conviction holds.

Time decay: If 90 days pass with no action in either direction — no sells, no buys, stock still below entry — the cluster becomes a data point rather than a signal. Conviction that never compounds is just money parked in a losing position.

I flagged this cluster because the pattern was strong: four insiders, $8.3 million, eight days, 52-week low, P/E of 6.7, consensus 57% upside. All of that was true then. Most of it is still true now. The stock just didn’t cooperate.

That’s the noise floor of insider analysis. Not every signal resolves in your favor. The honest move is to say so.